PSA launches new guide to naloxone supply

sad man in front of graffitied wall: harm minimisation story
A new guide to inform pharmacists about the safe and effective supply of naloxone has been released by the PSA. The comprehensive guide has been produced following the TGA’s decision to broaden the scheduling of naloxone – a life-saving medicine used to for opioid overdose – to include a Schedule 3 listing. This means from

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Opioid use quadruples in Australia, but others can't access pain relief
Next Dental health resources for cancer patients